NexCAR19 (Indigenous CAR-T)

Type: cell_therapy

Status: India: CDSCO Approved

Developer: ImmunoACT (IIT Bombay)

Breakthrough Summary

No summary available.

Mechanism of Action

India-developed CAR-T targeting CD19 at 1/15th the cost

Year: 2024